{"id":39945,"date":"2025-09-26T23:58:14","date_gmt":"2025-09-26T23:58:14","guid":{"rendered":"https:\/\/www.newsbeep.com\/il\/39945\/"},"modified":"2025-09-26T23:58:14","modified_gmt":"2025-09-26T23:58:14","slug":"etiology-and-antimicrobial-resistance-patterns-of-sepsis-in-infants-0-59-days-old-in-jimma-ethiopia-a-longitudinal-study-antimicrobial-resistance-infection-control","status":"publish","type":"post","link":"https:\/\/www.newsbeep.com\/il\/39945\/","title":{"rendered":"Etiology and antimicrobial resistance patterns of sepsis in infants 0\u201359 days old in Jimma, Ethiopia: a longitudinal study | Antimicrobial Resistance &#038; Infection Control"},"content":{"rendered":"<p>In 2000, the United Nations prioritized decreasing under-five mortality in the Millennium Development Goals (MDGs), recognizing the critical role of developing local health system capacity in improving childhood morbidity and mortality [<a data-track=\"click\" data-track-action=\"reference anchor\" data-track-label=\"link\" data-test=\"citation-ref\" aria-label=\"Reference 1\" title=\"Deribew A, Tessema GA, Deribe K, et al. Trends, causes, and risk factors of mortality among children under 5 in ethiopia, 1990\u20132013: findings from the global burden of disease study 2013. Popul Health Metr. 2016;14(1). &#010;                  https:\/\/doi.org\/10.1186\/s12963-016-0112-2&#010;                  &#010;                \" href=\"http:\/\/aricjournal.biomedcentral.com\/articles\/10.1186\/s13756-025-01626-2#ref-CR1\" id=\"ref-link-section-d105794304e644\" rel=\"nofollow noopener\" target=\"_blank\">1<\/a>]. Moreover, the sustainable development Goals (SDGs) and specifically, SDG 3.2 set the target of ending preventable death of newborns and children under 5 years of age, all countries aiming to reduce neonatal mortality to at least as low as 12 per 1000 live births and under 5 mortality to at least as low as 25 per 1000 live births by 2030 [<a data-track=\"click\" data-track-action=\"reference anchor\" data-track-label=\"link\" data-test=\"citation-ref\" aria-label=\"Reference 2\" title=\"UN. Transforming our world: the 2030 agenda for sustainable development. Resolution Adopted Gen Assembly 25 September 2015. 2015;42809:1\u201313. &#010;                  https:\/\/doi.org\/10.1007\/s13398-014-0173-7.2&#010;                  &#010;                \" href=\"http:\/\/aricjournal.biomedcentral.com\/articles\/10.1186\/s13756-025-01626-2#ref-CR2\" id=\"ref-link-section-d105794304e647\" rel=\"nofollow noopener\" target=\"_blank\">2<\/a>]. Even though Ethiopia was one of the few countries to achieve the MDG of a 67% decrease in under-five year old mortality, gains in neonatal mortality lagged substantially behind other age groups; contrary to the SDG target set, the neonatal mortality is in an increasing trend (increased from 29 per 1000 live births in 2016 to 33 per 1000 live births in 2019) [<a data-track=\"click\" data-track-action=\"reference anchor\" data-track-label=\"link\" data-test=\"citation-ref\" title=\"Deribew A, Tessema GA, Deribe K, et al. Trends, causes, and risk factors of mortality among children under 5 in ethiopia, 1990\u20132013: findings from the global burden of disease study 2013. Popul Health Metr. 2016;14(1). &#10;                  https:\/\/doi.org\/10.1186\/s12963-016-0112-2&#10;                  &#10;                \" href=\"#ref-CR1\" id=\"ref-link-section-d105794304e650\">1<\/a>,<a data-track=\"click\" data-track-action=\"reference anchor\" data-track-label=\"link\" data-test=\"citation-ref\" title=\"UN. Transforming our world: the 2030 agenda for sustainable development. Resolution Adopted Gen Assembly 25 September 2015. 2015;42809:1\u201313. &#10;                  https:\/\/doi.org\/10.1007\/s13398-014-0173-7.2&#10;                  &#10;                \" href=\"#ref-CR2\" id=\"ref-link-section-d105794304e650_1\">2<\/a>,<a data-track=\"click\" data-track-action=\"reference anchor\" data-track-label=\"link\" data-test=\"citation-ref\" aria-label=\"Reference 3\" title=\"Ethiopian Public Health Institute (EPHI) [Ethiopia] and ICF. Ethiopia mini demographic and health survey 2019: final report. Maryland, USA: EPHI and ICF: Rockville; 2021.\" href=\"http:\/\/aricjournal.biomedcentral.com\/articles\/10.1186\/s13756-025-01626-2#ref-CR3\" id=\"ref-link-section-d105794304e653\" rel=\"nofollow noopener\" target=\"_blank\">3<\/a>]. Globally, neonatal sepsis accounts for one-third of neonatal deaths and annually, there are estimated over 3\u00a0million infants 0-59days old dying, over 500,000 of them being due to possible serious bacterial infections (PSBI) [<a data-track=\"click\" data-track-action=\"reference anchor\" data-track-label=\"link\" data-test=\"citation-ref\" aria-label=\"Reference 4\" title=\"WHO Recommendations for Management of Serious Bacterial Infections in. Infants aged 0\u201359 days. 1st ed. Geneva: World Health Organization; 2025. p. 1.\" href=\"http:\/\/aricjournal.biomedcentral.com\/articles\/10.1186\/s13756-025-01626-2#ref-CR4\" id=\"ref-link-section-d105794304e656\" rel=\"nofollow noopener\" target=\"_blank\">4<\/a>].<\/p>\n<p>In infants 0\u201359 days old, symptoms and signs of serious bacterial infections like sepsis and meningitis are usually non-specific and overlapping, making distinction between the different spectrum of presentations difficult for health care providers. PSBI is defined as the presence of one or more of the below in infants 0\u201359 days old: fast breathing (respiratory rate of \u2265\u200960 per minute), movement only when stimulated, not feeding well on observation, temperature greater than or equal to 38\u00a0\u00b0C or less than 35.5\u00a0\u00b0C, severe chest in-drawing, convulsions, unable to feed at all, cyanosis, grunting, hypoxemia, lethargy\/unconciousness [<a data-track=\"click\" data-track-action=\"reference anchor\" data-track-label=\"link\" data-test=\"citation-ref\" title=\"WHO Recommendations for Management of Serious Bacterial Infections in. Infants aged 0\u201359 days. 1st ed. Geneva: World Health Organization; 2025. p. 1.\" href=\"#ref-CR4\" id=\"ref-link-section-d105794304e662\">4<\/a>,<a data-track=\"click\" data-track-action=\"reference anchor\" data-track-label=\"link\" data-test=\"citation-ref\" title=\"World Health Organization. Guideline: managing possible serious bacterial infection in young infants when referral is not feasible. Geneva: World Health Organization. 2015 [cited 2025 Aug 8]. Available from: &#10;                  https:\/\/iris.who.int\/handle\/10665\/181426&#10;                  &#10;                \" href=\"#ref-CR5\" id=\"ref-link-section-d105794304e662_1\">5<\/a>,<a data-track=\"click\" data-track-action=\"reference anchor\" data-track-label=\"link\" data-test=\"citation-ref\" aria-label=\"Reference 6\" title=\"The WHO AWaRe, Access. Watch, Reserve) antibiotic book. Geneva: World Health Organization; 2022. Licence: CC BY-NC-SA 3.0 IGO.\" href=\"http:\/\/aricjournal.biomedcentral.com\/articles\/10.1186\/s13756-025-01626-2#ref-CR6\" id=\"ref-link-section-d105794304e665\" rel=\"nofollow noopener\" target=\"_blank\">6<\/a>].<\/p>\n<p>The WHO recommendation for the management of PSBI in infants 0-59 days old is hospitalization and treatment with at least 7-days course of antibiotics (with a combination of injectable penicillin and gentamicin). If staphylococcal infection is suspected, a combination of cloxacillin and gentamicin is recommended [<a data-track=\"click\" data-track-action=\"reference anchor\" data-track-label=\"link\" data-test=\"citation-ref\" title=\"WHO Recommendations for Management of Serious Bacterial Infections in. Infants aged 0\u201359 days. 1st ed. Geneva: World Health Organization; 2025. p. 1.\" href=\"#ref-CR4\" id=\"ref-link-section-d105794304e671\">4<\/a>,<a data-track=\"click\" data-track-action=\"reference anchor\" data-track-label=\"link\" data-test=\"citation-ref\" title=\"World Health Organization. Guideline: managing possible serious bacterial infection in young infants when referral is not feasible. Geneva: World Health Organization. 2015 [cited 2025 Aug 8]. Available from: &#10;                  https:\/\/iris.who.int\/handle\/10665\/181426&#10;                  &#10;                \" href=\"#ref-CR5\" id=\"ref-link-section-d105794304e671_1\">5<\/a>,<a data-track=\"click\" data-track-action=\"reference anchor\" data-track-label=\"link\" data-test=\"citation-ref\" aria-label=\"Reference 6\" title=\"The WHO AWaRe, Access. Watch, Reserve) antibiotic book. Geneva: World Health Organization; 2022. Licence: CC BY-NC-SA 3.0 IGO.\" href=\"http:\/\/aricjournal.biomedcentral.com\/articles\/10.1186\/s13756-025-01626-2#ref-CR6\" id=\"ref-link-section-d105794304e674\" rel=\"nofollow noopener\" target=\"_blank\">6<\/a>]. However, inpatient treatment options are not accessible, acceptable or affordable to many infants and families in many of the developing countries. These challenges leave such infants without treatment and hence leading to unnecessary preventable deaths which is against SDG of ending preventable neonatal mortality [<a data-track=\"click\" data-track-action=\"reference anchor\" data-track-label=\"link\" data-test=\"citation-ref\" aria-label=\"Reference 2\" title=\"UN. Transforming our world: the 2030 agenda for sustainable development. Resolution Adopted Gen Assembly 25 September 2015. 2015;42809:1\u201313. &#010;                  https:\/\/doi.org\/10.1007\/s13398-014-0173-7.2&#010;                  &#010;                \" href=\"http:\/\/aricjournal.biomedcentral.com\/articles\/10.1186\/s13756-025-01626-2#ref-CR2\" id=\"ref-link-section-d105794304e677\" rel=\"nofollow noopener\" target=\"_blank\">2<\/a>, <a data-track=\"click\" data-track-action=\"reference anchor\" data-track-label=\"link\" data-test=\"citation-ref\" aria-label=\"Reference 5\" title=\"World Health Organization. Guideline: managing possible serious bacterial infection in young infants when referral is not feasible. Geneva: World Health Organization. 2015 [cited 2025 Aug 8]. Available from: &#010;                  https:\/\/iris.who.int\/handle\/10665\/181426&#010;                  &#010;                \" href=\"http:\/\/aricjournal.biomedcentral.com\/articles\/10.1186\/s13756-025-01626-2#ref-CR5\" id=\"ref-link-section-d105794304e680\" rel=\"nofollow noopener\" target=\"_blank\">5<\/a>]. In order to overcome these challenges and improve access to the treatment of PSBI in infants 0\u201359 days old, WHO issued guidance in 2015 [<a data-track=\"click\" data-track-action=\"reference anchor\" data-track-label=\"link\" data-test=\"citation-ref\" aria-label=\"Reference 5\" title=\"World Health Organization. Guideline: managing possible serious bacterial infection in young infants when referral is not feasible. Geneva: World Health Organization. 2015 [cited 2025 Aug 8]. Available from: &#010;                  https:\/\/iris.who.int\/handle\/10665\/181426&#010;                  &#010;                \" href=\"http:\/\/aricjournal.biomedcentral.com\/articles\/10.1186\/s13756-025-01626-2#ref-CR5\" id=\"ref-link-section-d105794304e683\" rel=\"nofollow noopener\" target=\"_blank\">5<\/a>] which was updated in 2024 [<a data-track=\"click\" data-track-action=\"reference anchor\" data-track-label=\"link\" data-test=\"citation-ref\" aria-label=\"Reference 6\" title=\"The WHO AWaRe, Access. Watch, Reserve) antibiotic book. Geneva: World Health Organization; 2022. Licence: CC BY-NC-SA 3.0 IGO.\" href=\"http:\/\/aricjournal.biomedcentral.com\/articles\/10.1186\/s13756-025-01626-2#ref-CR6\" id=\"ref-link-section-d105794304e687\" rel=\"nofollow noopener\" target=\"_blank\">6<\/a>] for outpatient treatment of PSBI to be used when referral for inpatient treatment is not possible or refused in infants 0-59 days old [<a data-track=\"click\" data-track-action=\"reference anchor\" data-track-label=\"link\" data-test=\"citation-ref\" aria-label=\"Reference 5\" title=\"World Health Organization. Guideline: managing possible serious bacterial infection in young infants when referral is not feasible. Geneva: World Health Organization. 2015 [cited 2025 Aug 8]. Available from: &#010;                  https:\/\/iris.who.int\/handle\/10665\/181426&#010;                  &#010;                \" href=\"http:\/\/aricjournal.biomedcentral.com\/articles\/10.1186\/s13756-025-01626-2#ref-CR5\" id=\"ref-link-section-d105794304e690\" rel=\"nofollow noopener\" target=\"_blank\">5<\/a>]. The guidance simplifies antibiotic selection for infants 0\u201359 days of age with PSBI in the absence of clinical microbiological data. Even if different clinical trials have been conducted on these simplified treatment of PSBI in infants 0\u201359 days old and demonstrated the efficacy and safety of these treatments [<a data-track=\"click\" data-track-action=\"reference anchor\" data-track-label=\"link\" data-test=\"citation-ref\" aria-label=\"Reference 7\" title=\"Tshefu A, Lokangaka A, Ngaima S, Engmann C, Esamai F, Gisore P, et al. Simplified antibiotic regimens compared with injectable procaine benzylpenicillin plus gentamicin for treatment of neonates and young infants with clinical signs of possible serious bacterial infection when referral is not possible: a randomised, open-label, equivalence trial. Lancet. 2015;385(9979):1767\u201376.\" href=\"http:\/\/aricjournal.biomedcentral.com\/articles\/10.1186\/s13756-025-01626-2#ref-CR7\" id=\"ref-link-section-d105794304e693\" rel=\"nofollow noopener\" target=\"_blank\">7<\/a>, <a data-track=\"click\" data-track-action=\"reference anchor\" data-track-label=\"link\" data-test=\"citation-ref\" aria-label=\"Reference 8\" title=\"Lokangaka A, Bauserman M, Coppieters Y, Engmann C, Qazi S, Tshefu A, et al. Simplified antibiotic regimens for treating neonates and young infants with severe infections in the Democratic Republic of congo: a comparative efficacy trial. Matern Health Neonatol Perinatol. 2018;4(1):8.\" href=\"http:\/\/aricjournal.biomedcentral.com\/articles\/10.1186\/s13756-025-01626-2#ref-CR8\" id=\"ref-link-section-d105794304e696\" rel=\"nofollow noopener\" target=\"_blank\">8<\/a>], its implementation in real life has not been conducted. Hence, supported by the WHO, between 2016 and 2017, Jimma and Mekelle Universities, institutions in different regions of Ethiopia, implemented the simplified management of PSBI in infants 0\u201359 days old when referral is not possible or refused at primary health care unit level using the 2015 WHO treatment guidelines. The implementation studies conducted in the two settings have demonstrated that the simplified treatment was acceptable and feasible from the care givers and health care workers perspectives [<a data-track=\"click\" data-track-action=\"reference anchor\" data-track-label=\"link\" data-test=\"citation-ref\" aria-label=\"Reference 9\" title=\"Berhane M, Girma T, Tesfaye W, Jibat N, Abera M, Abrahim S et al. Implementation research on management of sick young infants with possible serious bacterial infection when referral is not possible in Jimma Zone, Ethiopia: Challenges and solutions. Kose J, editor. PLOS ONE. 2021;16(8):e0255210.\" href=\"http:\/\/aricjournal.biomedcentral.com\/articles\/10.1186\/s13756-025-01626-2#ref-CR9\" id=\"ref-link-section-d105794304e699\" rel=\"nofollow noopener\" target=\"_blank\">9<\/a>, <a data-track=\"click\" data-track-action=\"reference anchor\" data-track-label=\"link\" data-test=\"citation-ref\" aria-label=\"Reference 10\" title=\"Leul A, Hailu T, Abraham L, Bayray A, Terefe W, Godefay H et al. Innovative approach for potential scale-up to jump-start simplified management of sick young infants with possible serious bacterial infection when a referral is not feasible: Findings from implementation research. Palinkas L, editor. PLOS ONE. 2021;16(2):e0244192.\" href=\"http:\/\/aricjournal.biomedcentral.com\/articles\/10.1186\/s13756-025-01626-2#ref-CR10\" id=\"ref-link-section-d105794304e702\" rel=\"nofollow noopener\" target=\"_blank\">10<\/a>]. The studies used for the development of the guidelines, including the African Neonatal Sepsis Trial (AFRINEST) [<a data-track=\"click\" data-track-action=\"reference anchor\" data-track-label=\"link\" data-test=\"citation-ref\" aria-label=\"Reference 7\" title=\"Tshefu A, Lokangaka A, Ngaima S, Engmann C, Esamai F, Gisore P, et al. Simplified antibiotic regimens compared with injectable procaine benzylpenicillin plus gentamicin for treatment of neonates and young infants with clinical signs of possible serious bacterial infection when referral is not possible: a randomised, open-label, equivalence trial. Lancet. 2015;385(9979):1767\u201376.\" href=\"http:\/\/aricjournal.biomedcentral.com\/articles\/10.1186\/s13756-025-01626-2#ref-CR7\" id=\"ref-link-section-d105794304e706\" rel=\"nofollow noopener\" target=\"_blank\">7<\/a>, <a data-track=\"click\" data-track-action=\"reference anchor\" data-track-label=\"link\" data-test=\"citation-ref\" aria-label=\"Reference 8\" title=\"Lokangaka A, Bauserman M, Coppieters Y, Engmann C, Qazi S, Tshefu A, et al. Simplified antibiotic regimens for treating neonates and young infants with severe infections in the Democratic Republic of congo: a comparative efficacy trial. Matern Health Neonatol Perinatol. 2018;4(1):8.\" href=\"http:\/\/aricjournal.biomedcentral.com\/articles\/10.1186\/s13756-025-01626-2#ref-CR8\" id=\"ref-link-section-d105794304e709\" rel=\"nofollow noopener\" target=\"_blank\">8<\/a>] multicenter trial, have focused almost exclusively on clinical outcomes, including treatment failure and mortality. However, these studies have not assessed the clinical microbiology and antimicrobial susceptibilities of PSBI in outpatient settings, so it remains unclear if the simplified antibiotic regimens recommended in the guidance are appropriate.<\/p>\n<p>Notably, the guidelines are standardized across the globe. Studies from Ethiopia and other low- and middle-income countries (LMICs) have found that the bacterial species responsible for neonatal infection differ from those in high-income countries (HICs), with higher rates of Staphylococcus aureus, Escherichia coli, and Klebsiella species and lower rates of Streptococcus agalactiae or \u201cGroup B Strep\u201d in LMICs [<a data-track=\"click\" data-track-action=\"reference anchor\" data-track-label=\"link\" data-test=\"citation-ref\" title=\"Demissie Shitaye D, Asrat Y, Woldeamanuel B, Worku. Risk factors and etiology of neonatal sepsis in Tikur Anbessa university hospital, Ethiopia. Ethiop Med J; 2010.\" href=\"#ref-CR11\" id=\"ref-link-section-d105794304e731\">11<\/a>,<a data-track=\"click\" data-track-action=\"reference anchor\" data-track-label=\"link\" data-test=\"citation-ref\" title=\"West BA, Peterside O. Sensitivity pattern among bacterial isolates in neonatal septicaemia in Port Harcourt. Ann Clin Microbiol Antimicrob. 2012;11(1):7.\" href=\"#ref-CR12\" id=\"ref-link-section-d105794304e731_1\">12<\/a>,<a data-track=\"click\" data-track-action=\"reference anchor\" data-track-label=\"link\" data-test=\"citation-ref\" title=\"Ogunlesi TA, Ogunfowora OB, Osinupebi O, Olanrewaju DM. Changing trends in newborn sepsis in sagamu, nigeria: bacterial aetiology, risk factors and antibiotic susceptibility. J Paediatr Child Health. 2011;47(1\u20132):5\u201311.\" href=\"#ref-CR13\" id=\"ref-link-section-d105794304e731_2\">13<\/a>,<a data-track=\"click\" data-track-action=\"reference anchor\" data-track-label=\"link\" data-test=\"citation-ref\" title=\"G\/eyesus T, Moges F, Eshetie S, Yeshitela B, Abate E. Bacterial etiologic agents causing neonatal sepsis and associated risk factors in gondar, Northwest Ethiopia. BMC Pediatr. 2017;17(1):137.\" href=\"#ref-CR14\" id=\"ref-link-section-d105794304e731_3\">14<\/a>,<a data-track=\"click\" data-track-action=\"reference anchor\" data-track-label=\"link\" data-test=\"citation-ref\" aria-label=\"Reference 15\" title=\"Milledge J, Calis JCJ, Graham SM, Phiri A, Wilson LK, Soko D, et al. Aetiology of neonatal sepsis in blantyre, malawi: 1996\u20132001. Ann Trop Paediatr. 2005;25(2):101\u201310.\" href=\"http:\/\/aricjournal.biomedcentral.com\/articles\/10.1186\/s13756-025-01626-2#ref-CR15\" id=\"ref-link-section-d105794304e734\" rel=\"nofollow noopener\" target=\"_blank\">15<\/a>]. Despite this discrepancy, in most of these studies, the antibiotics administered for PSBI in the inpatient setting in LMICs were similar to those administered in HICs: ampicillin or penicillin with gentamicin as first-line therapy and a 2nd or 3rd generation cephalosporin as second-line treatment. Some studies included oxacillin or cloxacillin as a first-line treatment, but this was uncommon. Moreover, several studies in Ethiopia and other LMICs have shown high rates of resistance to first- and second-line antimicrobials [<a data-track=\"click\" data-track-action=\"reference anchor\" data-track-label=\"link\" data-test=\"citation-ref\" aria-label=\"Reference 11\" title=\"Demissie Shitaye D, Asrat Y, Woldeamanuel B, Worku. Risk factors and etiology of neonatal sepsis in Tikur Anbessa university hospital, Ethiopia. Ethiop Med J; 2010.\" href=\"http:\/\/aricjournal.biomedcentral.com\/articles\/10.1186\/s13756-025-01626-2#ref-CR11\" id=\"ref-link-section-d105794304e737\" rel=\"nofollow noopener\" target=\"_blank\">11<\/a>, <a data-track=\"click\" data-track-action=\"reference anchor\" data-track-label=\"link\" data-test=\"citation-ref\" aria-label=\"Reference 14\" title=\"G\/eyesus T, Moges F, Eshetie S, Yeshitela B, Abate E. Bacterial etiologic agents causing neonatal sepsis and associated risk factors in gondar, Northwest Ethiopia. BMC Pediatr. 2017;17(1):137.\" href=\"http:\/\/aricjournal.biomedcentral.com\/articles\/10.1186\/s13756-025-01626-2#ref-CR14\" id=\"ref-link-section-d105794304e740\" rel=\"nofollow noopener\" target=\"_blank\">14<\/a>, <a data-track=\"click\" data-track-action=\"reference anchor\" data-track-label=\"link\" data-test=\"citation-ref\" aria-label=\"Reference 15\" title=\"Milledge J, Calis JCJ, Graham SM, Phiri A, Wilson LK, Soko D, et al. Aetiology of neonatal sepsis in blantyre, malawi: 1996\u20132001. Ann Trop Paediatr. 2005;25(2):101\u201310.\" href=\"http:\/\/aricjournal.biomedcentral.com\/articles\/10.1186\/s13756-025-01626-2#ref-CR15\" id=\"ref-link-section-d105794304e743\" rel=\"nofollow noopener\" target=\"_blank\">15<\/a>], and a recent review estimated resistance to both first- and second-line antimicrobials to be as high as 43\u201344% [<a data-track=\"click\" data-track-action=\"reference anchor\" data-track-label=\"link\" data-test=\"citation-ref\" aria-label=\"Reference 16\" title=\"Downie L, Armiento R, Subhi R, Kelly J, Clifford V, Duke T. Community-acquired neonatal and infant sepsis in developing countries: efficacy of who\u2019s currently recommended antibiotics\u2013systematic review and meta-analysis. Arch Dis Child. 2013;98(2):146\u201354.\" href=\"http:\/\/aricjournal.biomedcentral.com\/articles\/10.1186\/s13756-025-01626-2#ref-CR16\" id=\"ref-link-section-d105794304e746\" rel=\"nofollow noopener\" target=\"_blank\">16<\/a>]. Taken together, the effectiveness of the guidelines is likely to differ by setting, and likely, not be as effective in LMICs.<\/p>\n<p>Blood culture is the most important diagnostic test for identifying neonatal sepsis, allowing microbial identification and antibiotic susceptibility testing, which guide antibiotic selection. Unfortunately, due to the cost of blood culture, supply chain challenges, and laboratory capacity, many therapeutic decisions in LMICs including the study setting are made empirically using WHO or local guidelines [<a data-track=\"click\" data-track-action=\"reference anchor\" data-track-label=\"link\" data-test=\"citation-ref\" aria-label=\"Reference 4\" title=\"WHO Recommendations for Management of Serious Bacterial Infections in. Infants aged 0\u201359 days. 1st ed. Geneva: World Health Organization; 2025. p. 1.\" href=\"http:\/\/aricjournal.biomedcentral.com\/articles\/10.1186\/s13756-025-01626-2#ref-CR4\" id=\"ref-link-section-d105794304e753\" rel=\"nofollow noopener\" target=\"_blank\">4<\/a>]. The most common empiric treatment selections for PSBI were ampicillin and gentamicin, plus cloxacillin or a cephalosporin if there was concern for skin, bone, or joint infection. We aimed to compare the standard of care antibiotics provided per existing protocols to the antibiotic susceptibilities of the isolated microorganisms and develop local antibiogram to ascertain whether the existing WHO guidelines are appropriate for the treatment of PSBI in 0\u201359 days old infants admitted to Jimma University Hospital from March 2019 to March 2020.<\/p>\n","protected":false},"excerpt":{"rendered":"In 2000, the United Nations prioritized decreasing under-five mortality in the Millennium Development Goals (MDGs), recognizing the critical&hellip;\n","protected":false},"author":2,"featured_media":39946,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[10],"tags":[11495,9629,163,85,32306,4746,46,18494,32305,32308,32307,22296],"class_list":["post-39945","post","type-post","status-publish","format-standard","has-post-thumbnail","category-health","tag-antimicrobial-resistance","tag-drug-resistance","tag-health","tag-il","tag-infants","tag-infectious-diseases","tag-israel","tag-medical-microbiology","tag-neonates","tag-outcome","tag-possible-serious-bacterial-infections","tag-sepsis"],"_links":{"self":[{"href":"https:\/\/www.newsbeep.com\/il\/wp-json\/wp\/v2\/posts\/39945","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.newsbeep.com\/il\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.newsbeep.com\/il\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/il\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/il\/wp-json\/wp\/v2\/comments?post=39945"}],"version-history":[{"count":0,"href":"https:\/\/www.newsbeep.com\/il\/wp-json\/wp\/v2\/posts\/39945\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/il\/wp-json\/wp\/v2\/media\/39946"}],"wp:attachment":[{"href":"https:\/\/www.newsbeep.com\/il\/wp-json\/wp\/v2\/media?parent=39945"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.newsbeep.com\/il\/wp-json\/wp\/v2\/categories?post=39945"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.newsbeep.com\/il\/wp-json\/wp\/v2\/tags?post=39945"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}